Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

A Retrospective Study of C5b-9 and MASP2 Deposition in Skin Microvasculature As a Prognostic and Diagnostic Tool for Transplant-Associated Thrombotic Microangiopathy

Michael Daunov, John Sumodi, Nikki Agarwal, Molly Megan Gallogly, Leland Metheny, Ben K. Tomlinson, Rebecca B. Klisovic, Ali W. Bseiso, Brett Glotzbecker, Kord Honda, Koen van Besien

Blood (2024) 144 (Supplement 1): 2115.

https://doi.org/10.1182/blood-2024-212304

Published: 2024

Journal Articles

Next-Generation Sequencing to Assess the Impact of Low Dose Melphalan on Residual Disease before High-Dose Melphalan and Stem Cell Transplant in Multiple Myeloma

Ehsan Malek, Mary Hislop, Leland Metheny, III, Molly Gallogly, Marcos J.G. de Lima, Farhad Sanati, Hannah Elizabeth Schmikla, Brett Glotzbecker, James Driscoll

Blood (2021) 138 (Supplement 1): 4933.

https://doi.org/10.1182/blood-2021-148220

Published: 2021

Journal Articles

Epigenetic Priming with Pre-Transplant Oral Panobinostat Followed By Post-Transplant Consolidation

Ehsan Malek, Mary Hislop, Leland Metheny, III, Molly Gallogly, Brett Glotzbecker, Steve Stricker, James J. Driscoll

Blood (2021) 138 (Supplement 1): 2917.

https://doi.org/10.1182/blood-2021-151689

Published: 2021

Journal Articles

Incidence and Predictors of Hepatic Veno-Occlusive Disease after Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

Clinton Lewis, MD, Haesook T. Kim, PhD, Corey S. Cutler, MD MPH, John Koreth, MBBS, DPhil, Sarah Nikiforow, MD PhD, Mahasweta Gooptu, MD, Rizwan Romee, MD, Brett Glotzbecker, Prashant Nageshwar, MD, Edwin P. Alyea, III, MD, Joseph H. Antin, MD, Paul Richardson, Robert J. Soiffer, MD, Vincent T. Ho, MD

Blood (2018) 132 (Supplement 1): 3376.

https://doi.org/10.1182/blood-2018-99-113130

Published: 2018

Journal Articles

Phase II Trial of Natalizumab (Tysabri®) with Corticosteroids As Initial Treatment of Gastrointestinal Acute Graft Versus Host Disease

Natasha Kekre, MD FRCPC, Haesook T Kim, PhD, Vincent T Ho, MD, Yikun Guo, Umair Mahmood, Wafae Belatreche, John Koreth, MBBS, DPhil, Philippe Armand, MD PhD, Sarah Nikiforow, Edwin Alyea, III, MD, Prashant Nageshwar, MD, Brett Glotzbecker, Areej El-Jawahri, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Yi-Bin Chen, MD, Corey S. Cutler, MD MPH

Blood (2017) 130 (Supplement 1): 3252.

https://doi.org/10.1182/blood.V130.Suppl_1.3252.3252

Published: 2017

Journal Articles

Bortezomib-Based Versus Standard of Care Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation: A Phase II Randomized Controlled Trial

John Koreth, MD, Haesook T. Kim, PhD, Paulina B Lange, Philippe Armand, MD PhD, Corey S. Cutler, MD MPH, Vincent T. Ho, MD, Brett Glotzbecker, MD, Rushdia Z. Yusuf, MBBS, MPH, Sarah Nikiforow, MD PhD, Bimalangshu R. Dey, MD PhD, Malgorzata McMasters, MD, Jerome Ritz, MD, Bruce R. Blazar, MD, Robert J. Soiffer, MD, Joseph H Antin, MD, Edwin P. Alyea, MD

Blood (2016) 128 (22): 508.

https://doi.org/10.1182/blood.V128.22.508.508

Published: 2016

Journal Articles

A Systematic Approach to Providing Safe Quality Care for Patients Receiving Engineered, Non-Stem Cell Therapies

Sarah Nikiforow, MD PhD, Sarah Winawer-Wetzel, MBA, Sheila Phicil, MPH, Kurt Lowery, BS, Brett Glotzbecker, MD, Marsha Clements, MSN/ED, RN, Robert Mersereau, MS, Olive Sturtevant, MT, MHP, Ilene Galinsky, MSN, ANPc, William J Savage, MD, Edwin P. Alyea, III, MD, Robert J. Soiffer, MD, Craig Bunnell, MD MPH, MBA, Amy Emmert, MSc PH

Blood (2016) 128 (22): 2371.

https://doi.org/10.1182/blood.V128.22.2371.2371

Published: 2016

Journal Articles

A Bortezomib-Based Regimen Offers Excellent Outcomes In Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: Phase II Results

John Koreth, MBBS, DPhil, Haesook T. Kim, PhD, Paulina B. Lange, Bhavjot Bindra, Philippe Armand, MD, PhD, Corey S. Cutler, MD, Vincent T. Ho, MD, Brett Glotzbecker, MD, Jerome Ritz, MD, Bruce R Blazar, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Edwin P. Alyea, MD

Blood (2013) 122 (21): 3335.

https://doi.org/10.1182/blood.V122.21.3335.3335

Published: 2013

Journal Articles

Impact Of Umbilical Cord Unit Banking Conditions On Clinical Outcomes In Double Cord Transplant Recipients

Blood (2013) 122 (21): 695.

https://doi.org/10.1182/blood.V122.21.695.695

Published: 2013

Journal Articles

Risk Factors For Readmission Following Allogeneic Hematopoietic Stem Cell Transplantation and Impact On Overall Survival

Laura Spring, MD, Shuli Li, Robert J. Soiffer, MD, Joseph H. Antin, MD, Edwin P. Alyea, III, MD, Brett Glotzbecker, MD

Blood (2013) 122 (21): 555.

https://doi.org/10.1182/blood.V122.21.555.555

Published: 2013

Journal Articles

Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation

Blood (2013) 122 (17): 3074–3081.

https://doi.org/10.1182/blood-2013-05-503177

Published: 2013

Includes: Supplemental data

Journal Articles

Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial

Corey Cutler, Haesook T. Kim, Bhavjot Bindra, Stefanie Sarantopoulos, Vincent T. Ho, Yi-Bin Chen, Jacalyn Rosenblatt, Sean McDonough, Phandee Watanaboonyongcharoen, Philippe Armand, John Koreth, Brett Glotzbecker, Edwin Alyea, Bruce R. Blazar, Robert J. Soiffer, Jerome Ritz, Joseph H. Antin

Blood (2013) 122 (8): 1510–1517.

https://doi.org/10.1182/blood-2013-04-495895

Published: 2013

Journal Articles

A Phase I Study of Alemtuzumab Dosing for Steroid-Refractory Chronic Graft-Versus-Host Disease

Sarah Nikiforow, MD, PhD, Haesook T Kim, PhD, Bhavjot Bindra, Sean McDonough, MS, Brett Glotzbecker, MD, Philippe Armand, MD, PhD, John Koreth, MBBS, DPhil, Vincent T Ho, MD, Edwin P Alyea, III, MD, Jerome Ritz, MD, Robert J. Soiffer, MD, Joseph H. Antin, MD, Corey Cutler, MD, MPH, FRCPC

Blood (2012) 120 (21): 744.

https://doi.org/10.1182/blood.V120.21.744.744

Published: 2012

Journal Articles

Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation

Corey Cutler, Haesook T. Kim, Lixian Sun, Doreen Sese, Brett Glotzbecker, Philippe Armand, John Koreth, Vincent Ho, Edwin Alyea, Karen Ballen, Jerome Ritz, Robert J. Soiffer, Edgar Milford, Joseph H. Antin

Blood (2011) 118 (25): 6691–6697.

https://doi.org/10.1182/blood-2011-05-355263

Published: 2011

Journal Articles

Adoptive T Cell Therapy for Progressive Multifocal Leukoencephalopathy Using Sequential Ex-Vivo Stimulation with JCV Peptide Pulsed Dendritic Cells and Anti-CD3/CD28

Brett Glotzbecker, MD, Heidi Mills, BA, Jacalyn Rosenblatt, MD, Evelyn Bord, BS, Chen S Tan, MD, Sarah Gheuens, MD, Igor Koralnik, MD, David Avigan, MD

Blood (2011) 118 (21): 2175.

https://doi.org/10.1182/blood.V118.21.2175.2175

Published: 2011

Journal Articles

Low Levels of 25-Hydroxyvitamin D Prior to Allogeneic Transplantation Correlate with the Development of Chronic Graft-Versus-Host Disease,

Brett Glotzbecker, MD, Vincent T Ho, MD, Julie Aldridge, MS, Haesook T Kim, PhD, Gary Horowitz, MD, Jerome Ritz, MD, Robert J. Soiffer, MD, David Avigan, MD, Jacalyn Rosenblatt, MD

Blood (2011) 118 (21): 4063.

https://doi.org/10.1182/blood.V118.21.4063.4063

Published: 2011

Journal Articles

Addition of Clofarabine to TLI/ATG Conditioning: Impact on Immune Reconstitution and Clinical Outcomes,

Blood (2011) 118 (21): 4066.

https://doi.org/10.1182/blood.V118.21.4066.4066

Published: 2011

Journal Articles

MUC1 Inhibition Reverses the Poor Immunogenicity of Leukemia Stem Cells Rendering Them Susceptible to Immunotherapy

Dina Stroopinsky, PhD, Jacalyn Rosenblatt, MD, Heidi Mills, BA, Katarina Luptakova, MD, Brett Glotzbecker, MD, Baldev Vasir, PhD, Robin Joyce, MD, James Levine, MD, Dimitrios Tzachanis, MD, PhD, Jon E. Arnason, MD, Ilene Galinsky, ANP, Richard M. Stone, MD, Donald Kufe, MD, Yoram Reiter, PhD, David Avigan, MD

Blood (2011) 118 (21): 1883.

https://doi.org/10.1182/blood.V118.21.1883.1883

Published: 2011

Journal Articles

Lenalidomide Decreases PD-1 Expression, Depletes Regulatory T-Cells and Improves Cellular Response to a Multiple Myeloma/Dendritic Cell Fusion Vaccine In Vitro

Katarina Luptakova, MD, Brett Glotzbecker, MD, Heidi Mills, BA, Dina Stroopinsky, PhD, Baldev Vasir, PhD, Jacalyn Rosenblatt, MD, MSc, Donald Kufe, MD, David Avigan, MD

Blood (2010) 116 (21): 492.

https://doi.org/10.1182/blood.V116.21.492.492

Published: 2010

Journal Articles

Targeting Acute Myeloid Leukemia Stem Cells by MUC1-C Subunit Inhibition

Dina Stroopinsky, PhD, Jacalyn Rosenblatt, MD, MSc, Keisuke Ito, MD, PhD, Li Yin, Hasan Rajabi, PhD, Baldev Vasir, PhD, Turner Kufe, Brett Glotzbecker, MD, Katarina Luptakova, MD, Heidi Mills, BA, Robin Joyce, MD, Dimitrios Tzachanis, MD, PhD, Vassiliki A Boussiotis, MD, PhD, James Levine, MD, Ilene Galinsky, ANP, Richard Stone, MD, Pier Paolo Pandolfi, MD, PhD, Donald Kufe, MD, David Avigan, MD

Blood (2010) 116 (21): 848.

https://doi.org/10.1182/blood.V116.21.848.848

Published: 2010

NARROW

A Retrospective Study of C5b-9 and MASP2 Deposition in Skin Microvasculature As a Prognostic and Diagnostic Tool for Transplant-Associated Thrombotic Microangiopathy

Next-Generation Sequencing to Assess the Impact of Low Dose Melphalan on Residual Disease before High-Dose Melphalan and Stem Cell Transplant in Multiple Myeloma

Epigenetic Priming with Pre-Transplant Oral Panobinostat Followed By Post-Transplant Consolidation

Incidence and Predictors of Hepatic Veno-Occlusive Disease after Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

Phase II Trial of Natalizumab (Tysabri®) with Corticosteroids As Initial Treatment of Gastrointestinal Acute Graft Versus Host Disease

Bortezomib-Based Versus Standard of Care Reduced Intensity Conditioning Hematopoietic Stem Cell Transplantation: A Phase II Randomized Controlled Trial

A Systematic Approach to Providing Safe Quality Care for Patients Receiving Engineered, Non-Stem Cell Therapies

A Bortezomib-Based Regimen Offers Excellent Outcomes In Myeloablative HLA-Mismatched and Unrelated Donor Transplantation: Phase II Results

Impact Of Umbilical Cord Unit Banking Conditions On Clinical Outcomes In Double Cord Transplant Recipients

Risk Factors For Readmission Following Allogeneic Hematopoietic Stem Cell Transplantation and Impact On Overall Survival

Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation

Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial

A Phase I Study of Alemtuzumab Dosing for Steroid-Refractory Chronic Graft-Versus-Host Disease

Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation

Adoptive T Cell Therapy for Progressive Multifocal Leukoencephalopathy Using Sequential Ex-Vivo Stimulation with JCV Peptide Pulsed Dendritic Cells and Anti-CD3/CD28

Low Levels of 25-Hydroxyvitamin D Prior to Allogeneic Transplantation Correlate with the Development of Chronic Graft-Versus-Host Disease,

Addition of Clofarabine to TLI/ATG Conditioning: Impact on Immune Reconstitution and Clinical Outcomes,

MUC1 Inhibition Reverses the Poor Immunogenicity of Leukemia Stem Cells Rendering Them Susceptible to Immunotherapy

Lenalidomide Decreases PD-1 Expression, Depletes Regulatory T-Cells and Improves Cellular Response to a Multiple Myeloma/Dendritic Cell Fusion Vaccine In Vitro

Targeting Acute Myeloid Leukemia Stem Cells by MUC1-C Subunit Inhibition

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only